The molecular basis for oxidative stress-induced insulin resistance

Antioxidants and Redox Signaling

Volumn 7, Issue 7-8, 2005, Pages 1040-1052

  Evans, Joseph L ^a   Maddux, Betty A ^b   Goldfine, Ira D ^b  

^a Medical Research Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANISOMYCIN; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; METALLOTHIONEIN; PROTEIN SERINE THREONINE KINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TAURINE; THIOCTIC ACID; THIOREDOXIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; CELL DAMAGE; CHRONIC INFLAMMATION; CONTROLLED STUDY; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HEXOSE MONOPHOSPHATE SHUNT; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPOGENESIS; METABOLIC SYNDROME X; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REVIEW;

ANIMALS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES;

EID: 22044443268     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1040     Document Type: Review

References (157)

1. Adler V, Yin Z, Tew KD, and Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18: 6104-6111, 1999.
2. 307. J Biol Chem 275: 9047-9054, 2000.
3. 307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277: 1531-1537, 2002.
4. Arrigo AP. Gene expression and the thiol redox state. Free Radic Biol Med 27: 936-944, 1999.
5. Avruch J, Nemenoff RA, Blackshear PJ, Pierce MW, and Osathanondh R. Insulin-stimulated tyrosine phosphorylation of the insulin receptor in detergent extracts of human placental membranes. Comparison to epidermal growth factor-stimulated phosphorylation. J Biol Chem 257: 15162-15166, 1982.
6. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, and Brenner DA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394, 2003.
7. Beckman KB and Ames BN. The free radical theory of aging matures. Physiol Rev 78: 547-581, 1998.
8. Birnbaum MJ. Turning down insulin signaling. J Clin Invest 108: 655-659, 2001.
9. Blair AS, Hajduch E, Litherland GJ, and Hundal HS. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J Biol Chem 274: 36293-36299, 1999.
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
11. Bruce CR, Carey AL, Hawley JA, and Febbraio MA. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52: 2338-2345, 2003.
12. Burke TR Jr and Zhang ZY. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery. Biopolymers 47: 225-241, 1998.
13. Caballero B. Vitamin E improves the action of insulin. Nutr Rev 51:339-340, 1993.
14. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 49: 27-29, 2000.
15. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26: 1589-1596, 2003.
16. Cheatham B and Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 16: 117-142, 1995.
17. Cohen P. Dissection of protein kinase cascades that mediate cellular response to cytokines and cellular stress. Adv Pharmacol 36: 15-27, 1996.
18. ++-dependent thiol stimulation of glucose metabolism in white fat cells. J Biol Chem 247: 6218-6223, 1972.
19. 2+-dependent thiol activation of fat cell glucose utilization. J Biol Chem 249: 1001-1006, 1974.
20. Czech MP, Lawrence JC Jr, and Lynn WS. Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci U S A 71: 4173-4177, 1974.
21. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabet Rev 5: 177-269, 1997.
22. Denu JM and Dixon JE. Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr Opin Chem Biol 2: 633-541, 1998.
23. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
24. Evans JL and Jallal B. Protein tyrosine phosphatases: their role in insulin action and potential as drug targets. Exp Opin Invest Drugs 8: 139-160, 1999.
25. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
26. Evans JL, Heymann CJ, Goldfine ID, and Gavin LA. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled release formulation of α-lipoic acid. Endocr Pract 8: 29-35, 2002.
27. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52: 1-8, 2003.
28. Evans JL, Maddux BA, and Goldfine ID. Antioxidants in diabetic complications and insulin resistance. In: Diabetes: From Research to Diagnosis and Treatment, edited by Raz I, Skyler JS, and Shafrir E. London: Martin Dunitz, 2003, pp. 479-496.
29. Facchini FS, Hau NW, Reaven GM, and Stoohs RA. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radic Biol Med 29: 1302-1306, 2000.
30. Fauman EB and Saper MA. Structure and function of the protein tyrosine phosphatases. Trends Biochem Sci 21: 413-417, 1996.
31. Fenkci V, Fenkci S, Yilmazer M, and Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 80: 123-127, 2003.
32. Ford ES, Mokdad AH, Giles WH, and Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52: 2346-2352, 2003.
33. Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, and Lanzone A. N-Acetylcysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 77: 1128-1135, 2002.
34. Gamaley IA and Klyubin IV. Roles of reactive oxygen species: signaling and regulation of cellular functions. Int Rev Cytol 188: 203-255, 1999.
35. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, and Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277: 48115-48121, 2002.
36. Gao Z, Zuberi A, Quon MJ, Dong Z, and Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 278: 24944-24950, 2003.
37. Gardner CD, Eguchi S, Reynolds CM, Eguchi K, Frank GD, and Motley ED. Hydrogen peroxide inhibits insulin signaling in vascular smooth muscle cells. Exp Biol Med (Maywood) 228: 836-842, 2003.
38. Goldfine ID. The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev 8: 235-255, 1987.
39. Goldstein BJ. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity, and related states of insulin resistance. Curr Drug Targets Immune Endocr Metabol Disord 1: 265-275, 2001.
40. Gottschalk WK and Jarett L. Intracellular mediators of insulin action. Diabetes Metab Rev 1: 229-259, 1985.
41. Greene MW, Morrice N, Garofalo RS, and Roth RA. Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cδ. Biochem J 378 (Pt 1): 105-116, 2004.
42. Greene MW, Sakaue H, Wang L, Alessi DR, and Roth RA. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation. J Biol Chem 278: 8199-8211, 2003.
43. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, and Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
44. Gual P, Gonzalez T, Gremeaux T, Barres R, Marchand-Brustel Y, and Tanti JF. Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes. J Biol Chem 278: 26550-26557, 2003.
45. Haber CA, Lam TK, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, and Fantus IG. N-Acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 285: E744-E753, 2003.
46. Hager SR, Jochen AL, and Kalkhoff RK. Insulin resistance in normal rats infused with glucose for 72 h. Am J Physiol 260: E353-E362, 1991.
47. Halliwell B and Gutteridge JM. Free Radicals in Biology and Medicine. Oxford: Clarendon Press, 1999, pp. 1-936.
48. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298-300, 1956.
49. Harman D. The free radical theory of aging. Antioxid Redox Signal 5: 557-561, 2003.
50. Haruta T, Uno T, Kawahara J, Takano A, Egawa K, Sharma PM, Olefsky JM, and Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol 14: 783-794, 2000.
51. Hayes GR and Lockwood DH. Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc Natl Acad Sci U S A 84: 8115-8119, 1987.
52. Hemi R, Paz K, Wertheim N, Karasik A, Zick Y, and Kanety H. Transactivation of ErbB2 and ErbB3 by tumor necrosis factor-alpha and anisomycin leads to impaired insulin signaling through serine/threonine phosphorylation of IRS proteins. J Biol Chem 277: 8961-8969, 2002.
53. Henriksen EJ. Oxidative stress and antioxidant treatment: effects on muscle glucose transport in animal models of type 1 and type 2 diabetes. In: Antioxidants in Diabetes Management, edited by Packer L, Rosen P, Tritschler HJ, and King GL. New York: Marcel Dekker, 2000, pp. 303-317.
54. Henriksen EJ and Saengsirisuwan V. Exercise training and antioxidants: relief from oxidative stress and insulin resistance. Exerc Sport Sci Rev 31: 79-84, 2003.
55. Hirai N, Kawano H, Hirashima O, Motoyama T, Moriyama Y, Sakamoto T, Kugiyama K, Ogawa H, Nakao K, and Yasue H. Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C. Am J Physiol 279: H1172-H1178, 2000.
56. Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M, Kugiyama K, Ogawa H, and Yasue H. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol 35: 1860-1866, 2000.
57. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, and Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
58. Hitsumoto T, Iizuka T, Takahashi M, Yoshinaga K, Matsumoto J, Shimizu K, Kaku M, Sugiyama Y, Sakurai T, Aoyagi K, Kanai M, Noike H, Ohsawa H, Watanabe H, and Shirai K. Relationship between insulin resistance and oxidative stress in vivo. J Cardiol 42: 119-127, 2003.
59. Horike N, Takemori H, Katoh Y, Doi J, Min L, Asano T, Sun XJ, Yamamoto H, Kasayama S, Muraoka M, Nonaka Y, and Okamoto M. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J Biol Chem 278: 18440-18447, 2003.
60. Hundal RS, Mayerson AB, Petersen KF, Rife FS, Randhawa PS, Inzucchi SE, Shoelson SE, and Shulman GI. Potential for a novel class of insulin sensitizing agents by inhibition of IKKκ activity. Diabetes 50 (Suppl 2): A117, 2001.
61. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
62. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, and Shulman GI. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338: 867-872, 1998.
63. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, and Dietze GJ. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45: 872-874, 1995.
64. Jacob S, Henriksen EJ, Tritschler HJ, Augustin HJ, and Dietze GJ. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated patenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 104: 284-288, 1996.
65. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, and Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type 2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 27: 309-314, 1999.
66. Jiang G, Dallas-Yang Q, Liu F, Moller DE, and Zhang BB. Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells. J Biol Chem 278: 180-186, 2003.
67. Kasuga M, Zick Y, Blith DL, Karlsson FA, Haring HU, and Kahn CR. Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. J Biol Chem 257: 9891-9894, 1982.
68. Kasuga M, Zick Y, Blithe DL, Crettaz M, and Kahn CR. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298: 667-669, 1982.
69. Katz J and Wals PA. Effects of phenazine methosulfate on glucose metabolism in rat adipose tissue. Arch Biochem Biophys 147: 405-418, 1971.
70. Kellerer M, Mushack J, Seffer E, Mischak H, Ullrich A, and Haring HU. Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). Diabetologia 41: 833-838, 1998.
71. Kenner KA, Anyanwu E, Olefsky JM, and Kusari J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271: 19810-19816, 1996.
72. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, and Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108: 437-446, 2001.
73. Kohanski RA, Frost SC, and Lane MD. Insulin-dependent phosphorylation of the insulin receptor-protein kinase and activation of glucose transport in 3T3-L1 adipocytes. J Biol Chem 261: 12272-12281, 1986.
74. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, and Klip A. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50: 1464-1471, 2001.
75. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, and Usadel KH. Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22: 280-287, 1999.
76. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 89: 1006-1013, 1992.
77. 2 generation in human adipocyte plasma membranes is mediated by Galphai2. J Biol Chem 272: 10135-10143, 1997.
78. Kyriakis JM and Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 271: 24313-24316, 1996.
79. Kyriakis JM and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869, 2001.
80. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 11: 118-124, 1997.
81. Larner J, Cheng K, Schwartz C, Dubler R, Creacy S, Kikuchi K, Tamura S, Galasko G, Pullin C, and Katz M. Chemical mechanism of insulin action via proteolytic formation of mediator peptides. Mol Cell Biochem 40: 155-161, 1981.
82. Lawrence JC Jr and Larner J. Activation of glycogen synthase in rat adipocytes by insulin and glucose involves increased glucose transport and phosphorylation. J Biol Chem 253: 2104-2113, 1978.
83. Laybutt DR, Chisholm DJ, and Kraegen EW. Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats. Am J Physiol Endocrinol Metab 36: E1-E9, 1997.
84. Laybutt DR, Schmitz-Peiffer C, Saha AK, Ruderman NB, Biden TJ, and Kraegen EW. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. Am J Physiol 277: E1070-E1076, 1999.
85. Lee KU. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 54 Suppl 2: S29-S33, 2001.
86. Lee YH, Giraud J, Davis RJ, and White MF. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278: 2896-2902, 2003.
87. Li J, DeFea K, and Roth RA. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem 274: 9351-9356, 1999.
88. 2 formation. J Biol Chem 252: 560-562, 1977.
89. Livingston JN, Amatruda JM, and Lockwood DH. Studies of glucose transport system of fat cells: effects of insulin and insulin mimickers. Am J Physiol 234: E484-E488, 1978.
90. Maddux BA, See W, Lawrence JC Jr, Goldine AL, Goldfine ID, and Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 50: 404-410, 2001.
91. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, and Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669, 2001.
92. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
93. Malamas MS, Sredy J, Moxham C, Katz A, Xu W, McDevitt R, Adebayo FO, Sawicki DR, Seestaller L, Sullivan D, and Taylor JR. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1b with antihyperglycemic properties. J Med Chem 43: 1293-1310, 2000.
94. Malamas MS, Sredy J, McCaleb M, Gunawan I, Mihan B, and Sullivan D. Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones. Eur J Med Chem 36: 31-42, 2001.
95. May JM and de Haen C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J Biol Chem 254: 2214-2220, 1979.
96. May JM and de Haen C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem 254: 9017-9021, 1979.
97. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, and Petersen KF. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51: 797-802, 2002.
98. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18, 2002.
99. Morre DJ. Hormone- and growth factor-stimulated NADH oxidase. J Bioenerg Biomembr 26: 421-433, 1994.
100. Moxham CM and Malbon CC. Insulin action impaired by deficiency of the G-protein subunit G ialpha2. Nature 379: 840-844, 1996.
101. Mukherjee SP and Lynn WS. Reduced nicotinamide adenine dinucleotide phosphate oxidase in adipocyte plasma membrane and its activation by insulin. Possible role in the hormone's effects on adenylate cyclase and the hexose monophosphate shunt. Arch Biochem Biophys 184: 69-76, 1977.
102. Mukherjee SP and Mukherjee C. Stimulation of pyruvate dehydrogenase activity in adipocytes by oxytocin: evidence for mediation of the insulin-like effect by endogenous hydrogen peroxide independent of glucose transport. Arch Biochem Biophys 214: 211-222, 1982.
103. Nemoto S, Takeda K, Yu ZX, Ferrans VJ, and Finkel T. Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20: 7311-7318, 2000.
104. Obata T, Brown GE, and Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med 28: N67-N77, 2000.
105. Paolisso G and Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetologia 39: 357-363, 1996.
106. Paolisso G, Di Maro G, Pizza G, D'Amore A, Sgambato S, Tesauro P, Varricchio M, and D'Onofrio F. Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am J Physiol 263: E435-E440, 1992.
107. Paolisso G, D'Amore A, Volpe C, Balbi V, Saccomanno F, Galzerano D, Giugliano D, Varricchio M, and D'Onofrio F. Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 43: 1426-1429, 1994.
108. Paolisso G, Esposito R, D'Alessio MA, and Barbieri M. Primary and secondary prevention of atheroslcerosis: is there a role for antioxidants? Diabetes Metab 25: 298-306, 1999.
109. Patel S, Van Der Kaay J, and Sutherland C. Insulin regulation of hepatic insulin-like growth factor-binding protein-1 (IGFBP-1) gene expression and mammalian target of rapamycin (mTOR) signalling is impaired by the presence of hydrogen peroxide. Biochem J 365: 537-545, 2002.
110. Paz K, Voliovitch H, Hadari YR, Roberts CT, LeRoith D, and Zick Y. Interaction between the insulin receptor and its downstream effectors - use of individually expressed receptor domains for structure function analysis. J Biol Chem 271: 6998-7003, 1996.
111. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, and Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272: 29911-29918, 1997.
112. Pederson TM, Kramer DL, and Rondinone CM. Serine/ threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 50: 24-31, 2001.
113. Petersen KF and Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90: 11G-18G, 2002.
114. Potashnik R, Bloch-Damti A, Bashan N, and Rudich A. IRSl degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia 46: 639-648, 2003.
115. Qiao LY, Goldberg JL, Russell JC, and Sun XJ. Identification of enhanced serine kinase activity in insulin resistance. J Biol Chem 274: 10625-10632, 1999.
116. Qiao LY, Zhande R, Jetton TL, Zhou G, and Sun XJ. In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J Biol Chem 277: 26530-26539, 2002.
117. Rhee SG. Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31: 53-59, 1999.
118. Romero G, Luttrell L, Rogol A, Zeller K, Hewlett E, and Larner J. Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science 240: 509-511, 1988.
119. Rosen OM. After insulin binds. Science 237: 1452-1458, 1988.
120. Rosen OM, Herrera R, Olowe Y, Petruzzelli LM, and Cobb MH. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc Natl Acad Sci U S A 80: 3237-3240, 1983.
121. Rosen R, Nawroth PP, King G, Moller W, Tritschler HJ, and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association, and the German Diabetes Society. Diabetes Metab Res Rev 17: 189-212, 2001.
122. Rossetti L. Glucose toxicity - the implications of hyperglycemia in the pathophysiology of diabetes mellitus. Clin Invest Med 18: 255-260, 1995.
123. Rossetti L. Glucose toxicity: effect of chronic hyperglycemia on insulin action. In: Diabetes Mellitus: A Fundamental and Clinical Text, edited by LeRoith D, Taylor ST, and Olefsky JM. Philadelphia: Lippincott Williams & Wilkins, 2000, pp. 641-651.
124. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, and Santoro MG. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103-108, 2000.
125. Roth RA and Cassell DJ. Insulin receptor: evidence that it is aprotein kinase. Science 219: 299-301, 1983.
126. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, and Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 41: 1562-1569, 1998.
127. Rudich A, Tirosh A, Potashnik R, Khamaisi M, and Bashan N. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 42: 949-957, 1999.
128. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423: 769-773, 2003.
129. Saltiel AR, Fox JA, Sherline P, and Cuatrecasas P. Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase. Science 233: 967-972, 1986.
130. Senti M, Tomas M, Fito M, Weinbrenner T, Covas MI, Sala J, Masia R, and Marrugat J. Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 88: 5422-5426, 2003.
131. Sleight S, Wilson BA, Heimark DB, and Larner J. G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane vesicles. Biochem Biophys Res Commun 295: 561-569, 2002.
132. Smith SR, Bai F, Charbonneau C, Janderova L, and Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52: 1611-1618, 2003.
133. Smith-Johannsen H, Perdue JF, Ramjeesingh M, and Kahlenberg A. Involvement of membrane sulfhydryls in the activation and maintenance of nutrient transport in chick embryo fibroblasts. J Supramol Struct 7: 37-48, 1977.
134. 2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci U S A 97: 4844-4849, 2000.
135. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, and Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274: 10071-10078, 1999.
136. Sykiotis GP and Papavassiliou AG. Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. Mol Endocrinol 15: 1864-1869, 2001.
137. Tibbies LA and Woodgett JR. The stress-activated protein kinase pathways. Cell Mol Life Sci 55: 1230-1254, 1999.
138. Tirosh A, Potashnik R, Bashan N, and Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes-a putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274: 10595-10602, 1999.
139. Tirosh A, Rudich A, Potashnik R, and Bashan N. Oxidative stress impairs insulin but not platelet-derived growth factor signalling in 3T3-L1 adipocytes. Biochem J 355: 757-763, 2001.
140. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghamm H, Aljada A, and Dandona P. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52: 2882-2887, 2003.
141. Unger RH and Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119-121, 1985.
142. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, and Adachi Y. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88: 4673-4676, 2003.
143. van Montfort RL, Congreve M, Tisi D, Carr R, and Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423: 773-777, 2003.
144. West IC. Radicals and oxidative stress in diabetes. Diabet Med 17: 171-180, 2000.
145. White MF. 1RS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283: E413-E422, 2002.
146. Wittmann I and Nagy J. Are insulin resistance and atheroslerosis the consequences of oxidative stress? Diabetologia 39: 1002-1003, 1996.
147. Wood ZA, Poole LB, and Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300: 650-653, 2003.
148. Wrobel J, Li ZN, Dietrich A, McCaleb M, Mihan B, Sredy J, and Sullivan D. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl) thiazolidine-2,4-diones as antihyperglycemic agents. J Med Chem 41: 1084-1091, 1998.
149. Wu X, Hardy VE, Joseph JI, Jabbour S, Mahadev K, Zhu L, and Goldstein BJ. Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibition. Metabolism 52: 705-712, 2003.
150. Xia R, Webb JA, Gnall LL, Cutler K, and Abramson JJ. Skeletal muscle sarcoplasmic reticulum contains a NADH-dependent oxidase that generates superoxide. Am J Physiol Cell Physiol 285: C215-C221, 2003.
151. Yu K-T and Czech MP. Tyrosine phosphorylation of the insulin receptor β subunit activates the receptor-associated tyrosine kinase activity. J Biol Chem 259: 5277-5286, 1984.
152. Yu KT and Czech MP. Tyrosine phosphorylation of insulin receptor beta subunit activates the receptor tyrosine kinase in intact H-35 hepatoma cells. J Biol Chem 261: 4715-4722, 1986.
153. Yuan M, Lee J, Konstantopoulos N, Hansen L, and Shoelson SE. Salicylate inhibition of IKKβ (IκB kinase) reverses insulin resistance in Zucker (fa/fa) rats. Diabetes 49 (Suppl 1): A292, 2000.
154. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, and Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science 293: 1673-1677, 2001.
155. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, and Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38: 1395-1399, 2001.
156. Zhande R, Mitchell JJ, Wu J, and Sun XJ. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol Cell Biol 22: 1016-1026, 2002.
157. Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol 11: 437-441, 2001.